Category

Antitrust Law

Mark A. Lemley & Andrew McCreary (guest article): How Venture Capital’s “Exit Strategy” Drives Tech Industry Concentration

Dear readers, As previously announced, I am incredibly happy and honored to publish guest articles written by the world’s most renowned antitrust scholars every month of the year 2020. The one for September is authored by Mark A. Lemley, the William H. Neukom Professor at Stanford Law School and a partner at Durie Tangri LLP, & Andrew McCreary, a student at Stanford Law School and Stanford...
Read More

Newsletters for antitrust law enthusiasts

Last year, I published a list of podcasts for antitrust law enthusiasts. I am pleased to be posting a new list, this time around, about newsletters. Not all of them are antitrust-centered, but they (all) contribute to keeping me up-to-date. In fact, I find that reading them (religiously) is a small commitment from which I derive a significant benefit. So, here we...
Read More

Nicolas Petit (guest article): “Digital Markets and the Incipiency Attitude in EU Antitrust Law”

Dear readers, As previously announced, I am incredibly happy and honored to publish guest articles written by the world’s most renowned antitrust scholars every month of the year 2020. The one for September is authored by Nicolas Petit, Joint Chair in Competition Law at the European University Institute, and the Robert Schuman Center for Advanced Studies. In it, Nicolas explores the incipiency attitude in EU antitrust...
Read More

Antitrust law professors’ favorite articles

Last year, I asked European professors of competition law to list their three favorite articles ever written in the field (they’re here). Today, I am delighted to be publishing the American counterpart. About 30 antitrust law professors have sent me their contribution–for which I am very grateful. Our antitrust family doesn’t agree on everything (to say the...
Read More

Michael Carrier (guest article): “Why Do Courts Err in Pharmaceutical Antitrust Cases?”

Dear readers, As previously announced, I am incredibly happy and honored to publish guest articles written by the world’s most renowned antitrust scholars every month of the year 2020. The one for August is authored by Michael A. Carrier, Distinguished Professor of Law at Rutgers Law School. In it, Michael explores why courts have been making fundamental mistakes when it comes to pharmaceutical antitrust. I...
Read More

Google, Facebook, and Amazon are no platforms

It’s been a while since I wanted to write about Ben Thompson’s aggregation theory because it has significant implications for antitrust law. Today is the day I’m finally doing it. Yay. 1- Platforms vs. aggregators Before introducing the aggregation theory, I first need to explain why all tech giants are not platforms. According to the Historical Larousse dictionary, the term platform...
Read More

“Blockchain Code as Antitrust” in video

Dear all, Vitalik and I are very pleased to present you with this 12-minute video discussing (part of) our article entitled “Blockchain Code as Antitrust” (link). Thank you for watching!
Read More

Frédéric Jenny (guest article): “Market adjustments, Competition Law and the Covid-19 Pandemic”

Dear readers, As previously announced, I am incredibly happy and honored to publish guest articles written by several of the world’s most renowned antitrust scholars every month of the year 2020. The one for July is authored by Frédéric Jenny, Professor of Economics at ESSEC Business School, and Chairman of the OECD Competition Committee. In it, Frédéric discusses how competition agencies have been responding to the challenges...
Read More

A dialogue between Darwin and a blockchain

One day, Darwin encountered a young public permissionless blockchain. Here is the transcript of their conversation (all Darwin’s quotes are directly taken from his book, “On the Origin of Species“): Narrator: The blockchain is concerned about not fitting in the existing framework. The blockchain is not a market and is not a firm (see this article)....
Read More

A brief history of Article 102 TFEU

Today, the Bundesgerichtshof (German Federal Court of Justice) has sided with the Bundeskartellamt against Facebook (see). By doing so, the Court has deemed the absence of causality link between Facebook’s size on the market and its practice irrelevant. Once again, Facebook is being judged for combining WhatsApp, Instagram, and Facebook users’ data without their consent (but for improving these apps). Should I create...
Read More
1 2 3 7